Our unique in vivo technology is the perfect choice to test the whole-life effect of your lead compounds.
Thanks to our age-mimetic, high throughput platform we can economically screen entire chemical libraries or their combinations so you can quickly find the best anti-aging and rejuvenation candidates.
Longevity Biotechnology FAQ
Why should I use the C. elegans model for longevity studies?
C. elegans is the most suitable model for whole-life in vivo screening due to its short lifespan and well-known biology. Using low-cost and rapid C. elegans longevity assays can cut the time and financial requirements of the development process a dozen and up to 100-fold, respectively.
Have compounds with translational relevance been identified or tested in C. elegans for longevity benefits?
The vast majority of chemical compounds, more than 300, with anti-aging benefits have been identified and tested first in C. elegans. Candidates such as NAD+, metformin and urolithin have been tested in humans and are being (or have been) commercialized.
NemaLife chip: a micropillar-based microfluidic culture device optimized for aging studies in crawling C. elegans.
Tart Cherry Increases Lifespan in Caenorhabditis elegans by Altering Metabolic Signaling Pathways.
If my company orders a study through the screening service, how soon could we expect to receive the results?
Study time varies with volume and the type of testing ordered.
A typical whole-life study lasts about 6 weeks, short term and stress assays take about 2 weeks, including report writing.
I've heard about C elegans screening services in the past. What makes NemaLife different?
Our proprietary technology creates a highly sensitive, immersive testing environment, which allows us to test drugs at comparable concentrations to in-vitro and in vivo mammalian models. In addition, we offer multifactorial diversity assays that no other routine preclinical model currently offer.